Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Stomach Neoplasms × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 34 Neoplasms 5 Colorectal Neoplasms 4 Neoplasm Metastasis 3 Adenocarcinoma 3 Resectable Pancreatic Cancer 2 Rectal Neoplasms 2 Pancreatic Cancer Metastatic 2 Carcinoma, Hepatocellular 2 Urachal cancer 1 Stomach Neoplasms 1 Pancreatic Adenocarcinoma 1 Neoplasms, Basal Cell 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Localized Pancreatic Adenocarcinoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Islet Cell 1 Carcinoma 1 Borderline Resectable Pancreatic Cancer 1 Biliary Tract Neoplasms 1

Interventions

Oxaliplatin 257 Capecitabine 181 Fluorouracil 164 Cisplatin 145 Docetaxel 122 S 1 (combination) 116 Leucovorin 109 Paclitaxel 106 Irinotecan 97 pembrolizumab 86 Trastuzumab 56 apatinib 54 Nivolumab 49 Drug Therapy 39 sintilimab 36 Radiotherapy 35 Bevacizumab 34 Surgical Procedures, Operative 33 Ramucirumab 31 Carboplatin 29 titanium silicide 27 Hyperthermic Intraperitoneal Chemotherapy 27 Epirubicin 27 tislelizumab 26 Cyclophosphamide 24 XELOX 23 Tegafur 21 Folfox protocol 19 Cetuximab 19 camrelizumab 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03825861 2020-11-10

FOLFIRINOX

Instituto do Cancer do Estado de São Paulo

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡